Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain

Alexander, 1986, Parallel organization of functionally segregated circuits linking basal ganglia and cortex, Ann. Rev. Neurosci., 9, 357, 10.1146/annurev.ne.09.030186.002041 Altar, 1984, Clozapine, an atypical antipsychotic, attenuates haloperidol catalepsy, Pharmacologist, 26, 179 Altar, 1985, Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol, J. Pharmacol. Exp. Ther., 233, 527 Altar, 1986, Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain, Brain Res. Bull., 16, 517, 10.1016/0361-9230(86)90181-4 Balsara, 1979, Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy, Psychopharmacology, 62, 67, 10.1007/BF00426037 Baldessarini, 1979, Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia, Int. Rev. Neurobiol., 21, 1, 10.1016/S0074-7742(08)60636-4 Borison, 1983, Antipsychotic drug action: clinical, biochemical and pharmacological evidence for site specificity of actions, Clin. Neuropharmacol., 6, 137, 10.1097/00002826-198306000-00008 Borison, 1983, Regional selectivity of neuroleptic drugs: an argument for site specificity, Brain Res. Bull., 11, 215, 10.1016/0361-9230(83)90195-8 Boyson, 1988, Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum, J. Pharmacol. Exp. Ther., 987 Burki, 1986, Binding of psychoactive drugs to rat brain amine receptors, measured ex vivo and their effects on the metabolism of biogenic amines, Naunyn-Schmiedeberg's Arch. Pharmacol., 332, 258, 10.1007/BF00504864 Carter, 1978, A study of the sites of interaction between dopamine and 5-hydroxytryptamine for the production of fluphenazine-induced catalepsy, Naunyn-Schmiedeberg's Arch. Pharmacol., 304, 135, 10.1007/BF00495549 Carvey, 1988, Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation, Life Sci., 42, 2207, 10.1016/0024-3205(88)90372-4 Ceulemans, 1985, Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone, Psychopharmacology, 85, 329, 10.1007/BF00428197 Chiodo, 1983, Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons, J. Neurosci., 8, 1607, 10.1523/JNEUROSCI.03-08-01607.1983 Clements-Jewery, 1980, The in vivo and in vitro occupation of [3H]spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists, Neuropharmacology, 19, 657, 10.1016/0028-3908(80)90040-4 Costall, 1975, Serotoninergic involvement with neuroleptic catalepsy, Neuropharmacology, 14, 859, 10.1016/0028-3908(75)90114-8 Creese, 1976, Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs, Science, 192, 481, 10.1126/science.3854 DeSimoni, 1987, Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences, Brain Research, 411, 81, 10.1016/0006-8993(87)90683-4 Dubois, 1985, Heterogeneous distribution of dopamine D2 receptors within the rat stritum as revealed by autoradiography of[3H]N-n-propylnorapomorphine binding sites, Neurosci. Lett., 57, 7, 10.1016/0304-3940(85)90032-1 Eichenberger, 1984, Pharmacology of fluperlapine compared with clozapine, Arzneim.-Forsch./Drug Res., 34, 110 Falardeau, 1987, Regional effect of estradiol on rat caudate-putamen dopamine receptors: lateral-medial differences, Neurosci. Lett., 74, 43, 10.1016/0304-3940(87)90048-6 Fink, 1984, Clozapine — a serotonin antagonist?, Pharmacol. Biochem. Behav., 20, 513, 10.1016/0091-3057(84)90297-1 Gudelsky, 1987, Serotonergic antagonist properties of atypical antipsychotics, Soc. Neurosci. Abstr., 13, 800 Huger, 1987, Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 2. In vitro profile, Drug Dev. Res., 11, 169, 10.1002/ddr.430110304 Janssen, 1988, Pharmacology of risperidone (R64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties, J. Pharmacol. Exp. Ther., 244, 685 Joyce, 1986, Dopamine D2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation, Brain Research, 338, 209, 10.1016/0006-8993(85)90149-0 Klawans, 1980, Tardive dyskinesia: review and update, Am. J. Psychiatry, 137, 900, 10.1176/ajp.137.8.900 Kohler, 1981, Regional blockade by neuroleptic drugs of in vivo3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies, J. Neural Transm., 52, 163, 10.1007/BF01249601 Kostowski, 1972, Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated withp-chlorophenylalanine, Brain Research, 48, 443, 10.1016/0006-8993(72)90208-9 Lee, 1984, Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain, Psychiatry Res., 12, 277, 10.1016/0165-1781(84)90044-1 Miller, 1974, Anti-muscarinic properties of neuroleptics and drug-induced parkinsonism, Nature (Lond.), 248, 596, 10.1038/248596a0 Morgan, 1984, Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H)spiperone, Life Sci., 34, 2507, 10.1016/0024-3205(84)90288-1 Muller, 1978, Dopaminergic supersensitivity after neuroleptics: time-course and specificity, Psychopharmacology, 60, 1, 10.1007/BF00429171 Ogren, 1978, Studies on the stereoselective dopamine receptor blockade in the rat brain by rigid spiro amines, Life Sci., 23, 1769, 10.1016/0024-3205(78)90106-6 Ortmann, 1982, Correlations between different measures of antiserotonin activity of drugs. Study with neuroleptics and serotonin receptor blockers, Naunyn-Schmiedeberg's Arch. Pharmacol., 321, 265, 10.1007/BF00498511 Paxinos, 1982 Pisa, 1988, Motor functions of the striatum in the rat: critical role of the lateral region in tongue and forelimb reaching, Neuroscience, 24, 453, 10.1016/0306-4522(88)90341-7 Reynolds, 1982, Thioridazine is not specific for limbic DA receptors, Lancet, 2, 499, 10.1016/S0140-6736(82)90530-X Reynolds, 1983, Chronic clozapine treatment of rats down-regulates cortical 5-HT2 receptors, Eur. J. Pharmacol., 89, 325, 10.1016/0014-2999(83)90517-4 Rupniak, 1984, Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats, Psychopharmacology, 84, 512, 10.1007/BF00431458 Rupniak, 1985, Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat, Biochem. Pharmacol., 34, 2755, 10.1016/0006-2952(85)90577-5 Savasta, 1987, Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum, Neurosci. Lett., 74, 180, 10.1016/0304-3940(87)90146-7 Savasta, 1988, Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission, Neurosci. Lett., 85, 119, 10.1016/0304-3940(88)90440-5 Sayer, 1975, Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesia, effects of clozapine, haloperidol, loxapine and chlorpromazine, Psychopharmacologia, 41, 97, 10.1007/BF00421063 Seeger, 1979, Enhancement of self-stimulation behavior in rats and monkeys after chronic neuroleptic treatment: evidence for mesolimbic supersensitivity, Brain Research, 175, 49, 10.1016/0006-8993(79)90513-4 Seeger, 1982, Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol, Psychopharmacology, 76, 182, 10.1007/BF00435275 Seeman, 1976, Antipsychotic drug doses and neuroleptic/dopamine receptors, Nature (Lond.), 261, 717, 10.1038/261717a0 Seeman, 1983, Neuroleptics have identical potencies in human brain limbic and putamen regions, Eur. J. Pharmacol., 94, 145, 10.1016/0014-2999(83)90452-1 Seversen, 1984, Neuroleptic-induced striatal dopamine receptor supersensitivity in mice: relationship to dose and drug, Psychopharmacology, 84, 115, 10.1007/BF00432038 Snyder, 1974, Antischizophrenic drugs and brain cholinergic receptors, Arch. Gen. Psychiatry, 31, 58, 10.1001/archpsyc.1974.01760130040006 Szewczak, 1987, Pharmacological evaluation of HP 370, a potential atypical antipsychotic agent: 1. In vivo profile, Drug. Dev. Res., 11, 157, 10.1002/ddr.430110303 Tallarida, 1986 Von Voigtlander, 1975, Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment, J. Pharmacol. Exp. Ther., 193, 88 Waldemeier, 1979, Serotonin-dopamine interactions in the nigrostriatal system, Eur. J. Pharmacol., 55, 363, 10.1016/0014-2999(79)90110-9 Wander, 1987, Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal human brain in vitro, Eur. J. Pharmacol., 143, 279, 10.1016/0014-2999(87)90544-9 White, 1983, Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons, Science, 221, 1054, 10.1126/science.6136093